MenACWY-CRM Vaccine

BIOLOGICAL2 trials

Sponsors

Novartis Vaccines, Novartis

Conditions

Japanese EncephalitisMeningococcal DiseaseMeningococcal MeningitisPrevention of Meningococcal DiseaseRabiesTyphoidYellow Fever

Phase 2

Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children

CompletedNCT00262028

Novartis VaccinesPrevention of Meningococcal Disease

Start: 2005-04-30End: 2006-11-30Updated: 2016-02-11

Phase 3

A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults

CompletedNCT01466387

NovartisJapanese Encephalitis, Meningococcal Disease, Meningococcal Meningitis +3

Start: 2011-11-30End: 2012-04-30Updated: 2014-03-11

Related Papers

Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study.

2022-02-17292 citations

PELICAN-IPC 2015-016/Oncodistinct-003: A Prospective, Multicenter, Open-Label, Randomized, Non-Comparative, Phase II Study of Pembrolizumab in Combination With Neo Adjuvant EC-Paclitaxel Regimen in HER2-Negative Inflammatory Breast Cancer

Frontiers in Oncology2020-11-2510 citations

Abstract GS3-04: Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple negative, early high-risk and locally advanced breast cancer. NeoTRIPaPDL1 Michelangelo randomized study

Cancer Research2020-02-15134 citations

Safety and Immunogenicity of Typhoid Fever and Yellow Fever Vaccines When Administered Concomitantly With Quadrivalent Meningococcal ACWY Glycoconjugate Vaccine in Healthy Adults

Journal of Travel Medicine2014-10-1318 citations

Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: a randomized, open-label, multi-center study.

2014-05-0917 citations